Stent News and Research

RSS

A stent is a small mesh tube that’s used to treat narrowed or weakened arteries in the body.

You may have a stent placed in an artery as part of a procedure called angioplasty (AN-jee-oh-plas-tee). Angioplasty can restore blood flow through narrowed or blocked arteries. Stents help prevent arteries from becoming narrowed or blocked again in the months or years after treatment with angioplasty. You may also have a stent placed in a weakened artery to improve blood flow and to help prevent the artery from bursting.

Stents are usually made of metal mesh, but sometimes they’re made of fabric. Fabric stents, also called stent grafts, are used in larger arteries. Some stents are coated with medicines that are slowly and continuously released into the artery. These medicines help prevent the artery from becoming blocked again.

FDA approves GORE VIABAHN device to treat peripheral artery disease

W. L. Gore & Associates today announced it has received FDA approval for the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system.

17 Feb 2011

Spectranetics fourth quarter revenues decrease 1% to $29.3 million

Spectranetics Corporation today reported financial results for the quarter and full year ended December 31, 2010.

17 Feb 2011

Endologix announces initial PEVAR Trial presentation at 2011 iCON annual meeting

Endologix, developer of minimally invasive treatments for aortic disorders, announced today the presentation of the initial clinical results from the PEVAR Trial at the 2011 iCON annual meeting in Scottsdale, Arizona.

16 Feb 2011

Viewing knee as an organ could lead to better therapies for treatment of osteoarthritis

The human body is made up of several organs composed of tissues that enable them to perform a particular function. The heart circulates blood; the brain is the micro-neuro center of the body; the lungs bring in oxygen and release carbon dioxide.

15 Feb 2011

Cappella Medical presents new clinical data on Sideguard coronary sidebranch system at International JIM 2011

Cappella Medical Devices presented new clinical data on its unique Sideguard® coronary sidebranch system today at the International JIM 2011 in Rome, Italy.

11 Feb 2011

Study: Drug-eluting stents outperform BMS for revascularization of CTOs

A systematic review of medical evidence has determined drug-eluting stents outperform bare metal stents for revascularization of chronic total occlusions.

10 Feb 2011

Nine thousand patients to take part in Nowegian study on opening of narrowed coronary arteries

Nine thousand patients will take part in a clinical trial to determine the best method of opening narrowed coronary arteries. The results of the study may lead to substantial cost savings - and save lives.

9 Feb 2011

Reducing the cardiovascular disease gender gap

The European Society of Cardiology (ESC) is working with the National Cardiac Societies of its 53 member countries on a project to raise awareness of the disturbing gender gap in cardiovascular disease (CVD). In partnership with the European Heart Network (EHN) and the World Heart Federation (WHF), the ESC has developed the Women@Heart contest in which national societies submit ideas for public awareness campaigns aimed at informing both health professionals and women of the dangers of complacency about CVD.

8 Feb 2011

New replacement valve can help patients to avoid multiple open-heart surgeries

Congenital heart defects are the most common type of major birth defects in the U.S., affecting about 34,000 babies each year. Twenty percent of these patients are born with a malformation of the pulmonary valve, which is a flap-like opening on the right side of the heart that is responsible for regulating the blood flow to the lungs. Now, a new replacement valve being used at Rush University Medical Center can help patients with damaged heart valves delay or avoid multiple open-heart surgeries.

3 Feb 2011

Researchers design nanoparticles that make blood clots visible to CT scanner

For almost two decades, cardiologists have searched for ways to see dangerous blood clots before they cause heart attacks. Now, researchers at Washington University School of Medicine in St. Louis report that they have designed nanoparticles that find clots and make them visible to a new kind of X-ray technology.

3 Feb 2011

FDA approves FSS's FlexStent system IDE for OPEN Trial

Flexible Stenting Solutions, a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received full FDA Investigational Device Exemption approval for its FlexStent Femoropopliteal Self Expanding Stent System.

2 Feb 2011

Boston Scientific fourth quarter net sales decrease 4% to $2.002 billion

Boston Scientific Corporation today announced financial results for the fourth quarter and full year ended December 31, 2010, as well as net sales and earnings per share (EPS) guidance for the full year and first quarter 2011.

2 Feb 2011

Widespread screening or ultrasound for blocked neck arteries not necessary to determine stroke risk

Widespread screening or routine ultrasound for blocked neck arteries to determine stroke risk isn't necessary, according to new guidelines from the American Heart Association/American Stroke Association, American College of Cardiology and other groups.

1 Feb 2011

Favorable clinical results from Endologix's Nellix technology against EVAR

Endologix, developer of minimally invasive treatments for aortic disorders, announced today the publication of favorable clinical results for the Nellix technology for the endovascular repair of abdominal aortic aneurysm.

1 Feb 2011

Abbott receives US regulatory clearance and Japanese approval for TREK Coronary Dilatation Catheters

Abbott today announced it has received regulatory clearance in the United States and approval in Japan for its TREK and MINI-TREK Coronary Dilatation Catheters for the treatment of coronary artery disease. The TREK system is used in angioplasty procedures and is designed to enable interventional cardiologists to open patients' narrowed coronary arteries. The TREK system received CE Mark and was launched in Europe in May 2010.

1 Feb 2011

Cappella initiates multi-center Italian Sideguard open label clinical study

Cappella Medical Devices announces initiation of the multi-center Italian Sideguard® open label clinical study. The Principal Investigator (PI) of the study, Dr. Giuseppe Massimo Sangiorgi at the Policlinico di Modena - University of Modena and Reggio Emilia, in Modena, Italy stated, "The side branch ostium anatomy requires a unique technology solution to effectively manage and optimize treatment.

1 Feb 2011

Roundup: Calif. wrestles with prison health costs; Texas legislator challenges GOP thinking; Mass. Gov. seeks remedy for municipal workers' health expenses

Amid California's budget crisis, the receiver put in charge of the prison health system by a federal judge has spent $82 million on blueprints for medical facilities that have been largely scrapped, more than $50,000 a month on an architectural consultant and millions hiring medical professionals — more per inmate than in many other states.

27 Jan 2011

Major changes at Journal of Vascular and Interventional Radiology

The Journal of Vascular and Interventional Radiology-the monthly, peer-reviewed flagship publication of the Society of Interventional Radiology-announced several major changes for 2011-all directed at highlighting the global impact of this minimally invasive medical specialty and its lead journal.

27 Jan 2011

IDEV announces release of SUPERA stent data from Leipzig Registry

IDEV Technologies, Incorporated, an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced the release of two-year European data from the prominent Leipzig Registry, which tracks patients treated with the SUPERA wire interwoven nitinol stent.

27 Jan 2011

FDA approves Corindus CorPath 200 System for pivotal trial to evaluate safety, effectiveness

Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced it has been granted Food and Drug Administration conditional Investigational Device Exemption approval to evaluate the safety and effectiveness of its CorPath® 200 System in delivering and manipulating coronary guidewires and stent/balloon systems in percutaneous coronary interventions procedures.

27 Jan 2011

Stent News and Research

Further Reading

FDA approves GORE VIABAHN device to treat peripheral artery disease

Spectranetics fourth quarter revenues decrease 1% to $29.3 million

Endologix announces initial PEVAR Trial presentation at 2011 iCON annual meeting

Viewing knee as an organ could lead to better therapies for treatment of osteoarthritis

Cappella Medical presents new clinical data on Sideguard coronary sidebranch system at International JIM 2011

Study: Drug-eluting stents outperform BMS for revascularization of CTOs

Nine thousand patients to take part in Nowegian study on opening of narrowed coronary arteries

Reducing the cardiovascular disease gender gap

New replacement valve can help patients to avoid multiple open-heart surgeries

Researchers design nanoparticles that make blood clots visible to CT scanner

FDA approves FSS's FlexStent system IDE for OPEN Trial

Boston Scientific fourth quarter net sales decrease 4% to $2.002 billion

Widespread screening or ultrasound for blocked neck arteries not necessary to determine stroke risk

Favorable clinical results from Endologix's Nellix technology against EVAR

Abbott receives US regulatory clearance and Japanese approval for TREK Coronary Dilatation Catheters

Cappella initiates multi-center Italian Sideguard open label clinical study

Roundup: Calif. wrestles with prison health costs; Texas legislator challenges GOP thinking; Mass. Gov. seeks remedy for municipal workers' health expenses

Major changes at Journal of Vascular and Interventional Radiology

IDEV announces release of SUPERA stent data from Leipzig Registry

FDA approves Corindus CorPath 200 System for pivotal trial to evaluate safety, effectiveness

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News